4.7 Review

Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome

期刊

JOURNAL OF CLINICAL MEDICINE
卷 10, 期 4, 页码 -

出版社

MDPI
DOI: 10.3390/jcm10040610

关键词

ischemic heart disease; chronic coronary syndrome; coronary artery disease; myocardial revascularization; ischemia; stress cardiac magnetic resonance

资金

  1. Instituto de Salud Carlos III
  2. Fondos Europeos de Desarrollo Regional FEDER [PI20/00637, PI17/01836, CIBERCV16/11/00486, CIBER-CV16/11/00420]

向作者/读者索取更多资源

The development of coronary revascularization techniques has been crucial in reducing mortality rates in acute coronary syndrome, but controversial in extending life expectancy in patients with chronic coronary syndrome.
Ischemic heart disease (IHD) persists as the leading cause of death in the Western world. In recent decades, great headway has been made in reducing mortality due to IHD, based around secondary prevention. The advent of coronary revascularization techniques, first coronary artery bypass grafting (CABG) surgery in the 1960s and then percutaneous coronary intervention (PCI) in the 1970s, has represented one of the major breakthroughs in medicine during the last century. The benefit provided by these techniques, especially PCI, has been crucial in lowering mortality rates in acute coronary syndrome (ACS). However, in the setting where IHD is most prevalent, namely chronic coronary syndrome (CCS), the increase in life expectancy provided by coronary revascularization is controversial. Over more than 40 years, several clinical trials have been carried out comparing optimal medical treatment (OMT) alone with a strategy of routine coronary revascularization on top of OMT. Beyond a certain degree of symptomatic improvement and lower incidence of minor events, routine invasive management has not demonstrated a convincing effect in terms of reducing mortality in CCS. Based on the accumulated evidence more than half a century after the first revascularization procedures were used, invasive management should be considered in those patients with uncontrolled symptoms despite OMT or high-risk features related to left ventricular function, coronary anatomy, or functional assessment, taking into account the patient expectations and preferences.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据